CHEK2 and neoplasm: The results of this study, by demonstrating clear divergences in the impact of dysregulation of ATM, ATR, and CHK2 on important tumor characteristics, shed new insight into how early decisions to turn off cell cycle regulation can direct the course of ensuing disease.